Here are 1-2 brief analogies for Streamex (STEX), based on the provided company description:

• A specialized Medtronic or Boston Scientific for enhancing the clarity of heart electrical signals in electrophysiology.
• The Dolby for cardiac electrophysiology, providing clearer, real-time signals for heart rhythm treatments.

null

null

null

Henry McPhie, Chief Executive Officer

Henry McPhie is the Co-Founder and Chief Executive Officer of Streamex, leading the company's mission to revolutionize real-world asset tokenization and bring commodities on-chain through cutting-edge blockchain solutions. A seasoned entrepreneur and visionary technologist, he has a strong track record of building innovative companies at the intersection of blockchain and finance. Prior to founding Streamex, Mr. McPhie founded Lynx Web3 Solutions, a blockchain incubation and software development firm. He also founded FatCats Capital, a Solana-based NFT project that quickly became the third largest in the world at the time of its launch, cultivating a global community of over 100,000 members. He holds a degree in Mining Engineering from McGill University.

Morgan Lekstrom, Executive Chairman

Morgan Lekstrom is the Co-Founder and Executive Chairman of Streamex. He is a seasoned mining executive and corporate strategist with over 17 years of experience building and transforming resource companies, bringing deep expertise in capital markets, strategic M&A, and commodities. Mr. Lekstrom previously served as CEO of NexMetals Mining Corp., where he developed critical metals projects in Botswana with US$150 million backing from the Export-Import Bank of the United States. As President of NexGold Mining, he orchestrated strategic transformations through mergers. His global experience includes senior technical roles at Freeport McMoran's Grasberg mine and Rio Tinto's Oyu Tolgoi project. He co-founded Streamex with Henry McPhie approximately 3.5 years ago and is one of the largest shareholders.

Ferdinand Groenewald, Chief Financial Officer

Ferdinand Groenewald is the Chief Financial Officer of Streamex Corp. He is a certified public accountant with significant experience in finance and accounting. Mr. Groenewald currently serves as Vice President, Finance at Alaunos Therapeutics, Inc. His previous roles include serving as an Independent Outside Director at SYLA Technologies Co., Ltd., HeartCore Enterprises, Inc., and Sushi Ginza Onodera, Inc. He also held positions as an Accountant at Wrinkle, Gardner & Co. PC, a Senior Staff Accountant at Financial Consulting Strategies LLC, a Controller, VP-Finance & Accounting Officer, and Chief Financial Officer at Sadot Group, Inc., and Chief Accounting Officer & VP-Finance at Muscle Maker Development LLC. Mr. Groenewald obtained an undergraduate degree from the University of South Africa.

Mitchell Williams, CFA, Chief Investment Officer

Mitchell Williams, CFA, is the Chief Investment Officer of Streamex, a position he has held since 2025. He brings over 20 years of experience from Wall Street, consistently driving performance through strategic insight, innovation, and disciplined investment management. Mr. Williams began his investment career at Credit Suisse on the Internet Financial Services team during the Web 1.0 era. He went on to hold senior executive roles at OppenheimerFunds and Wafra Inc., where he managed multi-billion dollar global and domestic equity portfolios and led high-performing investment teams. At Wafra, he grew assets under management more than threefold and achieved top-quartile performance. At OppenheimerFunds, he was a highly ranked equity analyst and sole portfolio manager for one of the firm's flagship funds. Prior to his current role, he served as a Strategic Advisor on Capital Markets for Streamex. He earned an MBA from NYU Stern School of Business (where he was a Stern Fellowship recipient) and a BA from the University of Florida.

Russell Starr, Head of Capital Markets

Russell Starr was appointed Head of Capital Markets for Streamex. He brings over 25 years of capital markets experience, spanning US Capital Markets, emerging technology, tokenized finance, and Web3 infrastructure.

• Regulatory Approval and Compliance Risk: As a medical device company, Streamex (BioSig Technologies, Inc.) faces significant and ongoing risks associated with obtaining and maintaining regulatory approvals (e.g., FDA clearance) for its PURE EP system and any future product enhancements or new therapies. Failure to secure or sustain these approvals, or to comply with stringent medical device regulations, could prevent the company from marketing its products or lead to product recalls and significant penalties.
• Market Adoption and Commercialization Risk: The success of Streamex's PURE EP system relies heavily on its adoption by electrophysiologists and medical institutions. There is a risk that healthcare providers may not widely adopt the system, either due to a lack of perceived clinical benefit over existing solutions, high acquisition costs, challenges in integration into current workflows, or insufficient market education and sales efforts. Slow or limited market penetration would negatively impact revenue and growth.
• Competition and Technological Obsolescence Risk: The medical device market, particularly in specialized fields like electrophysiology, is highly competitive and subject to rapid technological advancements. Streamex faces risks from competitors developing superior, more cost-effective, or alternative technologies that could render the PURE EP system less competitive or even obsolete. The need to continually innovate and differentiate its products, as indicated by collaborations for AI/machine learning and novel therapies, highlights this ongoing challenge.

null

Streamex (STEX), formerly known as BioSig Technologies, Inc., has undergone a significant corporate rebranding and shifted its strategic focus from medical devices to real-world asset (RWA) tokenization and gold-related financial infrastructure. The addressable markets for Streamex's main products and services are as follows:

Real-World Asset (RWA) Tokenization Market

The market for tokenized real-world assets is experiencing rapid growth globally. As of early 2026, the market size for tokenized RWAs has reached over $25 billion, a nearly fourfold increase from approximately $6.4 billion a year prior. Other estimates place the current RWA market at roughly $19–$22 billion in January 2026 and $24 billion in June 2025. Looking ahead, the projections for the RWA tokenization market are substantial:

• McKinsey estimated that tokenized financial assets could reach approximately $2 trillion by 2030, excluding cryptocurrencies and stablecoins.
• Citi GPS forecasts growth to almost $4 trillion by 2030, particularly in private markets.
• Roland Berger's 2023 report projects the market to be at least $10.9 trillion by 2030.
• Boston Consulting Group (BCG) and ADDX estimate a market size of $16.1 trillion by 2030.
• Ark Invest suggests tokenized assets could grow to about $11 trillion by 2030.
• Other experts predict that $16-30 trillion of real-world assets will be tokenized by 2030.
• A broader market report estimates the global asset tokenization market was valued at USD 2.06 trillion in 2024 and is expected to reach USD 41.94 trillion by 2032, growing at a CAGR of 45.83% over 2025-2032.
• The U.S. asset tokenization market specifically was valued at USD 0.57 trillion in 2024 and is expected to reach USD 11.55 trillion by 2032.
• Standard Chartered projects the market to reach $30.1 trillion by 2034.

Gold Tokenization Market

The tokenized gold market has shown significant momentum. Its total market capitalization surpassed $6 billion as of February 2026, marking a gain of approximately $2 billion year-to-date. In Q4 2025, the tokenized gold market cap added nearly $2.8 billion in net value, moving from $1.6 billion to $4.4 billion. Forecasts for tokenized gold indicate continued expansion:

• Wintermute anticipates the tokenized gold market to reach $15 billion in 2026 due to accelerated institutional adoption.
• Analysts expect tokenized gold to become a foundational layer of RWA tokenization, a sector projected to exceed $16 trillion by 2030.

On-Chain Commodity Markets

The broader tokenized commodities sector, which includes gold, has also seen substantial growth. The cumulative market capitalization of the tokenized commodities sector increased by 10% over the past month to $7.69 billion as of March 2026. For the global commodity services market (a broader category that includes traditional commodity services in addition to on-chain offerings), the size was estimated at USD 4885.29 billion in 2026 and is projected to reach USD 8045.73 billion by 2035. Another report estimated the global commodity services market at USD 3.56 billion in 2024, predicted to increase to approximately USD 8.16 billion by 2034.

Streamex Corp. (STEX), formerly BioSig Technologies, Inc., underwent a significant strategic transformation in September 2025, pivoting its business model from medical devices to real-world asset (RWA) tokenization. The company now focuses on building institutional-grade infrastructure for gold tokenization and broader on-chain commodity markets. Its offerings include gold-backed financial instruments and regulated, yield-bearing digital assets like its GLDY token. Based on this strategic shift and current business focus, the following are expected drivers of future revenue growth for Streamex over the next 2-3 years:

1. Growth in Real-World Asset (RWA) Tokenization Market Adoption: As a company primarily focused on RWA tokenization, particularly with gold-backed assets, Streamex's revenue growth is intrinsically linked to the increasing adoption and institutional acceptance of tokenized real-world assets. The expansion of this nascent market, driven by perceived benefits like increased liquidity, transparency, and fractional ownership, would directly translate into higher demand for Streamex's tokenization and trading infrastructure services.

2. Expansion of Tokenized Commodity Offerings: While gold tokenization is a primary focus, Streamex's vertically integrated platform is designed to bring a broader range of commodities on-chain. Expanding its offerings beyond gold to include other precious metals or commodities would open new revenue streams and attract a wider array of institutional and retail investors seeking diversified tokenized asset exposure.

3. Strategic Partnerships and Institutional Integrations: Collaborations with asset managers, financial institutions, and other key players in the digital asset ecosystem are crucial for Streamex's growth. The company has explicitly stated its aim to integrate tokenized gold into regulated investment products and leverage strategic partnerships. For example, Streamex recently announced a letter of intent with Simplify Asset Management to explore strategic partnerships to drive ETF innovation through the integration of tokenized gold yield assets and tokenization of existing ETFs. Such partnerships can significantly increase the reach and utility of Streamex's tokenized products, driving transaction volumes and platform usage.

4. Development and Adoption of Yield-Bearing Digital Assets: Streamex is developing and offering yield-bearing gold products. The success and widespread adoption of these innovative financial products, such as its GLDY token backed by physical gold, could be a significant revenue driver. Attracting investors with the potential for yield on traditionally non-yielding assets like gold would differentiate Streamex and expand its customer base.

Here is a summary of Streamex's capital allocation decisions over the last 3-5 years:

Share Issuance

• In August 2025, Streamex completed a public offering, raising approximately $15 million in gross proceeds from the sale of 3,852,149 shares of common stock at $3.90 per share. The company planned to use these proceeds to purchase gold bullion, for general corporate purposes, and for working capital.
• In March 2025, the company sold 758,514 shares of common stock and issued warrants to certain accredited investors, generating an aggregate of $818,998.
• In September 2025, shareholders approved an increase in the number of authorized shares of common stock from 200 million to 500 million.

Inbound Investments

• In July 2025, the company entered into definitive agreements with an institutional investor for up to $1.1 billion in growth financing. This included an offering of $75 million in senior secured convertible debentures and an equity line of credit.

Outbound Investments

• Around June 2025, BioSig Technologies, Inc. acquired Streamex Exchange Corporation, incurring total acquisition-related costs of approximately $7.1 million, which included the issuance of common stock to third-party consultants. This acquisition marked a strategic shift towards real-world asset tokenization.
• The company has acquired an equity interest in a royalty and streaming company to expand its exposure to gold and silver royalty and streaming assets.

Capital Expenditures

• Amortization expenses for intangible assets increased significantly from $10 for the six months ended June 30, 2024, to $545 for the six months ended June 30, 2025, primarily due to intangible assets acquired in connection with the Streamex acquisition (e.g., trade name, developed technology, legal and compliance framework).
• Proceeds from an August 2025 public offering, approximately $15 million, were intended to be used for the purchase of gold bullion, aligning with the company's investment policy for its new gold tokenization business model.